Your session is about to expire
← Back to Search
Opioid Medications for Opioid Use Disorder
Study Summary
This trial is meant to study how opioid use and withdrawal affects people's decision-making, and to look for ways to help those with opioid addiction.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I don't have any major health or mental issues that would stop me from following the study's requirements.I do not have vision or hearing problems that would stop me from completing study tasks.I have a substance use disorder needing detox, not including opioids or nicotine.I have difficult veins for IV access and will be in the remifentanil study part.I am using an effective form of birth control.
- Group 1: Active treatment followed by placebo treatment
- Group 2: Placebo treatment followed by active treatment
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this clinical trial represent a revolutionary approach to medical research?
"To date, 47 trials are in progress for the drug Remifentanil across 14 nations and 53 cities. The first survey of its kind was completed by Medtronic - MITG back in 2009 with a cohort size of 80 participants. Since then, 521 investigations have been conducted on this medication."
Is enrollment in this trial still open?
"Affirmative. Clinicaltrials.gov attests to the fact that recruitment for this medical experiment initiated on August 16th 2019 and was recently updated in February 2022. 31 patients need to be enrolled across one test centre."
Could I be a potential participant in this research endeavor?
"Qualified contenders for this medical trial should be suffering from opioid use disorder and fall between 18-50 years of age. Currently, the team is aiming to source 31 patients."
What is the current participant quota for this research project?
"Affirmative. Clinicaltrials.gov affirms that the trial, first posted on August 16th 2019 and recently modified on February 10th 2022, is actively recruiting 31 participants at one medical centre."
Are adults of eighteen years or older able to join in this experiment?
"In accordance with the trial's criteria, individuals aged 18-50 are eligible to apply for inclusion in this study."
What are the principal applications of Remifentanil?
"Remifentanil is traditionally used to alleviate pain, however its application has been extended to include management of moderate pain and monitored anesthesia care sedation."
What other investigations have been undertaken to explore the efficacy of Remifentanil?
"Remifentanil is presently being examined in 47 separate clinical trials, with 11 of them reaching the late stage 3. Most of these studies are based in Shenzhen, Guangdong; however, there are 87 other sites carrying out research into this drug."
Who else is applying?
What state do they live in?
How old are they?
What portion of applicants met pre-screening criteria?
What site did they apply to?
Share this study with friends
Copy Link
Messenger